Mimulus

Mimulus: A Comprehensive Encyclopedic Reference

1. Identity: Botanical Classification, Nomenclature, and Natural Sources

Genus and Family

Mimulus /ˈmɪmjuːləs/, also known as monkeyflowers, is a plant genus in the family Phrymaceae, which was traditionally placed in the family Scrophulariaceae. The name is derived from the Latin mimulus, a diminutive of mimus, meaning comic or mimic actor, alluding to the monkey-faced corolla of some species.

Modern Taxonomic Revision

The genus now contains only seven species, two native to eastern North America and the other five native to Asia, Australia, Africa, or elsewhere. In the 2012 restructuring of Mimulus by Barker et al., based largely upon DNA evidence, seven species were left in Mimulus, 111 placed into Erythranthe (species with axile placentation and long pedicels), 46 placed into Diplacus (species with parietal placentation and sessile flowers), and additional species placed in Uvedalia, Elacholoma, Mimetanthe, and Thyridia.

This taxonomic restructuring is significant for understanding the literature on Mimulus as a dietary supplement or natural ingredient, because a large fraction of the scientific, ethnobotanical, and popular usage refers to species that are now formally classified in other genera. The most prominent example is the common yellow monkeyflower, Mimulus guttatus DC., which is the species traditionally used in the famous Bach flower remedy system and extensively studied as an ethnobotanical plant. This species was given its first scientific name, Mimulus guttatus, in 1813 by Augustin Pyramus de Candolle, but in 2012 it was moved to the genus Erythranthe by Guy L. Nesom, giving the species its accepted name Erythranthe guttata. Nevertheless, it was formerly known as Mimulus guttatus, and in that context is still widely referred to as Mimulus guttatus throughout the scientific literature.

Similarly, Mimulus aurantiacus, a bush monkeyflower whose resin chemistry has been studied pharmacologically, is now formally assigned to Diplacus aurantiacus. Mimulus bigelovii, the source of antiparasitic compounds identified in peer-reviewed research, is now placed in Diplacus bigelovii. Throughout this article, species are referred to by their historically familiar Mimulus binomials, consistent with the majority of phytochemical and ethnobotanical literature, with current accepted names noted where relevant.

Key Species of Botanical or Medicinal Relevance

In addition to those in North America, additional Mimulus species (in the strictly defined modern sense) are natives of the Eastern and Southern hemispheres, including M. aquatilis A. R. Bean (northeastern Australia), M. bracteosus P. C. Tsoong (southeastern China), M. gracilis R. Brown (Australia), M. madagascariensis Bentham (Madagascar), M. orbicularis Wallich ex Bentham (mainland Southeast Asia), and M. strictus Bentham (Africa, India).

The species most directly relevant to supplement and folk medicine contexts are:

• Mimulus guttatus DC. (syn. Erythranthe guttata) — Common yellow monkeyflower or seep monkeyflower; principal species used in Bach flower remedies and in Native American medicine. A herbaceous wildflower, it grows along the banks of streams and seeps throughout much of western North America from sea level to 12,000 feet (3,700 m).
• Mimulus bigelovii (syn. Diplacus bigelovii) — Bigelow's monkeyflower; the source of antiparasitic geranylated flavonoids identified in pharmacological screening.
• Mimulus aurantiacus (syn. Diplacus aurantiacus) — Sticky or bush monkeyflower; studied for its geranyl-α-pyrone leaf resin chemistry.

Botanical Description and Habitat

Plants are herbs, perennial, terrestrial or semi-aquatic. Stems are ascending to erect, 4-angled, winged, sometimes narrowly, glabrous. Leaves are basal and cauline, opposite; blades sometimes semi-fleshy, with dentate to subentire margins and brochidodromous venation. Erythranthe guttata occurs as both annual and perennial forms throughout its range. It blooms during spring at low elevations and during summer at high elevations. It is found in a wide range of habitats including the splash zone of the Pacific Ocean, the chaparral of California, western U.S. deserts, the geysers of Yellowstone National Park, alpine meadows, serpentine barrens, and even on the toxic tailings of copper mines.

Common Preparations and Forms

Mimulus (as the genus was traditionally defined) appears in commercial and traditional contexts in several distinct forms:

• Bach flower essence: Bach flower remedies (BFRs) are solutions of brandy and water — the water containing extreme dilutions of flower material — developed by Edward Bach, an English medical doctor. The Bach flower remedy solutions contain a 50:50 mix of water and brandy, and are called mother tincture. The solutions do not have a characteristic scent or taste of the plant because of dilution.
• Herbal decoctions and poultices: Traditional Indigenous preparations of stems, leaves, and flowers made as teas, steam baths, or topical poultices.
• Fresh or dried leaves: Used as food by various Native American groups and recorded as edible by ethnobotanists. Leaves may be eaten raw or cooked, with a slightly bitter flavor, added to salads.
• Methanolic and hydroalcoholic extracts: Used in laboratory phytochemical and pharmacological studies (not commercially available as consumer products).

---

2. Traditional and Historical Use

Native American Ethnobotanical Use

Mimulus guttatus has been used for food and medicine for a variety of purposes by North American indigenous peoples. Ethnobotanical records document diverse applications across multiple tribal groups:

• Kawaiisu (analgesic): A decoction of stems and leaves was used as a steam bath for chest and back soreness.
• Mendocino Indian (food): Plants were used as a substitute for lettuce.
• Miwok (food): Boiled leaves were used for food.
• Shoshoni (dermatological aid): A poultice of crushed leaves was applied to wounds or rope burns.
• Yavapai (gastrointestinal aid): A decoction was taken as a tea for stomachache.

The plant is generally characterized in ethnobotanical literature as astringent, poultice, and vulnerary. A decoction of the leaves and stems was used as a herbal steam bath for chest and back soreness. A poultice of the crushed leaves was applied to wounds, rope burns, and similar injuries.

Edible Uses

The leaves are edible, both raw and cooked. Leaves are sometimes added to salads as a lettuce substitute and have a slight bitter flavor. In the scientific context, Erythranthe guttata (formerly Mimulus guttatus) is a model organism for biological studies, and there may be as many as 1,000 scientific papers focused on this species.

The Bach Flower Remedy Tradition (20th Century Onwards)

The most widely recognized modern traditional use of Mimulus as a supplement or remedy is as one of Dr. Edward Bach's 38 flower essences.

Bach flower remedies date back to the 1920s and 1930s when the British doctor Edward Bach developed them. He believed that flowers and plants contain energy that can heal emotional issues. Bach devoted his life to the discovery of 38 remedies that correspond to 38 negative emotional states.

Within the Bach system, Mimulus occupies a specific and well-defined role. Mimulus is described as the remedy for known fears. Whenever one is frightened or anxious about something, and can say what that "something" is, then Mimulus is the indicated remedy. Mimulus fears are those of everyday life: fear of public speaking, of the dark, of aggressive dogs, of illness and pain. Phobias can also be Mimulus fears if the cause of the fear — whether spiders, birds, or open spaces — can be named.

Mimulus is also used as a type or personality remedy for those who tend generally to be nervous, timid, and shy — people who might blush easily or stammer, and who will usually avoid social occasions and any event where they will be in the limelight.

The preparation method in the Bach system is based on the infusion of flowers in spring water under sunlight, followed by preservation in brandy. The liquid, called the mother tincture, is filtered and mixed with brandy, which acts as a preservative. The remedies can be taken orally diluted in a glass of water, or applied directly to pulse points such as the wrists, temples, and behind the ears.

---

3. Key Constituents and Active Compounds

The phytochemistry of the Mimulus genus (broadly defined) has been investigated in only a limited number of species. The most detailed phytochemical work concerns M. guttatus (now Erythranthe guttata) and M. bigelovii (now Diplacus bigelovii).

Phenylpropanoid Glycosides (PPGs) in Mimulus guttatus

Yellow monkeyflower (Mimulus guttatus DC., Phrymaceae) has long been a model plant species for studies in genetics, evolution, and ecology, including plant-animal interactions. Nonetheless, exceedingly little was known about its secondary chemistry. Researchers have discovered that the foliage of yellow monkeyflower contains a diverse suite of phenylpropanoid glycosides (PPGs), a class of compounds with many known biological activities.

Using ¹H and ¹³C NMR and UV and MS chromatography techniques, five PPGs were positively identified from the leaves of yellow monkeyflower. Four of these compounds occur in other species and one is previously undescribed. UV and high-resolution tandem MS data also putatively identified 11 additional foliar compounds as PPGs.

The identified PPGs include verbascoside, isoverbascoside, calceolarioside, conandroside, and one novel compound designated mimuloside. These compounds are a chemically diverse group with documented antimicrobial, antioxidant, and anti-inflammatory properties in other plant systems, though no pharmacological studies have been conducted specifically on Mimulus guttatus extracts in humans. This initial discovery and elucidation of yellow monkeyflower's secondary chemistry will be important for continued study of the genetics and ecology of this model species.

C-Geranyl Flavonoids in Mimulus bigelovii

Bioactivity-directed fractionation of the methanol fraction of the extract of Mimulus bigelovii by means of an axenic Leishmania amastigote assay and chromatographic techniques resulted in the isolation of four C-geranyl flavanones — diplacone (1), 3′-O-methyldiplacone (2), 4′-O-methyldiplacone (3), 3′-O-methyldiplacol (4) — together with a geranylated flavone, cannflavin A (5). These compounds were separated from M. bigelovii for the first time.

Geranyl-α-Pyrone from Mimulus aurantiacus Leaf Resin

Research cited in the scientific literature (Hare and Borchardt, 2002) describes the structure of a geranyl-α-pyrone from Mimulus aurantiacus leaf resin, adding to the documented diversity of terpenoid-linked compounds in the broader monkeyflower alliance. The structure of a geranyl-α-pyrone from Mimulus aurantiacus leaf resin has been characterized in the phytochemical literature.

Carotenoids

The flowers of certain Mimulus species contain unique carotenoid pigments. Mimulaxanthin is among the carotenoid compounds identified in the flowers of Mimulus lewisii and related species. These allenic carotenoid pigments are of scientific interest primarily for their evolutionary and biosynthetic significance rather than for human health applications.

Compound Classes Documented in the Broader Genus

Based on the limited phytochemical literature available, the secondary metabolites documented across the Mimulus alliance include:

• Phenylpropanoid glycosides (verbascoside, isoverbascoside, calceolarioside, conandroside, mimuloside) — in M. guttatus foliage
• C-geranyl and geranylated flavanones and flavones (diplacone, 3′-O-methyldiplacone, 4′-O-methyldiplacone, 3′-O-methyldiplacol, cannflavin A) — in M. bigelovii
• Geranyl pyrones — in M. aurantiacus leaf resin
• Allenic carotenoids (mimulaxanthin) — in M. lewisii flowers

It must be emphasized that phytochemical knowledge of the genus remains at an early stage. Exceedingly little is known about the secondary chemistry of Mimulus guttatus, and this assessment applies with equal or greater force to most other members of the former broader Mimulus genus.

---

4. Scientific Evidence by Area of Use

4.1 Antiparasitic Activity (In Vitro Evidence Only)

The most directly relevant pharmacological investigation of a Mimulus species in peer-reviewed literature concerns the antiparasitic properties of C-geranyl flavonoids isolated from Mimulus bigelovii.

Study design and results: Bioactivity-directed fractionation of the methanol extract of Mimulus bigelovii using an axenic Leishmania amastigote assay yielded four C-geranyl flavanones and one geranylated flavone (cannflavin A). These compounds were separated from M. bigelovii for the first time. All compounds showed moderate antileishmanial activity against axenic Leishmania donovani amastigotes with IC₅₀ values ranging from 4.8 to 14.6 μg/mL. The compounds were also tested against the related kinetoplastid parasite Trypanosoma brucei brucei, and they showed activity with IC₅₀ values ranging from 1.4 to 7.2 μg/mL.

More specifically, four C-geranyl flavones (diplacone, 3′-O-methyldiplacone, yellow oil, and 3′-O-methyldiplacol) and one geranylated flavone (cannflavin A) were isolated from Mimulus bigelovii. The IC₅₀ value was determined to be 7.5 μg/mL for both 3′-O-methyldiplacone and yellow oil against axenic amastigotes. 3′-O-Methyldiplacol obtained an IC₅₀ value of 7.2 μg/mL, and cannflavin A obtained an IC₅₀ value of 14.6 μg/mL, both tested against axenic amastigotes.

Evidence strength: This is purely in vitro (cell-based) data from isolated compounds. There are no animal model studies or human clinical trials evaluating Mimulus extracts for antiparasitic indications. The evidence is preliminary and exploratory only.

4.2 Emotional and Psychological Uses — Bach Flower Remedy Context (Clinical Trial Evidence)

The predominant context in which Mimulus is presented as a supplement or remedy for human use is as one of Dr. Bach's 38 flower essences. This is the area with the greatest body of clinical evaluation, though not specifically targeting Mimulus in isolation.

Systematic Reviews and RCTs

A systematic review assessed whether Bach Flower Remedies (BFRs) are safe and efficacious by searching MEDLINE, Embase, AMED, and the Cochrane Library from inception until June 2008, and performing a hand-search of references from relevant key articles. Efficacy was assessed by including all prospective studies with a control group, and safety by also including retrospective observational studies with more than 30 subjects. Two authors abstracted data and determined risk of bias. Four randomised controlled trials (RCTs) and two additional retrospective observational studies were identified and included in the review.

Three RCTs of BFRs for students with examination anxiety and one RCT of BFRs for children with attention-deficit hyperactivity disorder (ADHD) showed no overall benefit in comparison to placebo. Due to the number and quality of the studies, the strength of the evidence is low.

A separate systematic review restricted to randomised clinical trials reached a consistent conclusion. Seven such studies were located. All but one were placebo-controlled. All placebo-controlled trials failed to demonstrate efficacy. It is concluded that the most reliable clinical trials do not show any differences between flower remedies and placebos.

All placebo-controlled trials failed to demonstrate significant efficacy of flower remedies. Only one trial lacked a placebo group, and its results are unreliable due to small sample size.

Evidence strength (Bach flower remedy uses, including Mimulus): Multiple systematic reviews of RCTs consistently find no clinically significant benefit beyond placebo. The quality and number of trials are limited, but the direction of evidence is clearly negative for efficacy claims. The hypothesis that flower remedies are associated with effects beyond a placebo response is not supported by data from rigorous clinical trials.

Mechanistic Plausibility

The solutions do not have a characteristic scent or taste of the plant because of dilution. The dilution process results in the statistical likelihood that little more than a single molecule may remain; it is claimed that the remedies contain an "energetic" or "vibrational" nature of the flower and that this can be transmitted to the user. No credible pharmacological mechanism has been proposed or demonstrated for ultra-dilute flower essences, and the claimed mechanism has no established basis in chemistry or pharmacology.

4.3 Wound Healing and Analgesic Uses (Traditional Evidence Only)

The ethnobotanical record describes uses of M. guttatus for wound healing and pain relief by multiple Native American cultures. However, no formal clinical or preclinical studies have been conducted to evaluate these uses. The plant's characterization as "astringent" and "vulnerary" in traditional herbal references (the plant is described as astringent, poultice, and vulnerary) is consistent with the tannin and phenylpropanoid glycoside content documented chemically, but no pharmacological trials support these traditional uses.

4.4 Gastrointestinal Uses (Traditional Evidence Only)

The Yavapai used a decoction taken as tea for stomachache. No scientific study has investigated Mimulus preparations for gastrointestinal endpoints in animals or humans.

---

5. Body Systems and Health Areas Associated with Mimulus

• Nervous system / emotional wellbeing: The primary area of use in contemporary supplement contexts, via the Bach flower essence tradition. Indicated within that system for fear, anxiety, timidity, and shyness — specifically fears of known origin.
• Musculoskeletal / dermatological system: Traditional Indigenous use for chest and back soreness (steam bath decoction) and topical wound care (poultice).
• Gastrointestinal system: Traditional use as a tea for stomachache (Yavapai).
• Antiparasitic potential: Preclinical in vitro activity of isolated geranylated flavonoids against Leishmania donovani and Trypanosoma brucei.
• Nutrition / food use: Leaves documented as a food source, used raw or cooked as a leafy vegetable or lettuce substitute by multiple California Indigenous groups.

---

6. Dosage Forms and Dosages Reported in Sources

Bach Flower Essence (Mimulus)

The liquid, called the mother tincture, is filtered and mixed with brandy, which acts as a preservative. The remedies can be taken orally diluted in a glass of water, or applied directly to pulse points such as the wrists, temples, and behind the ears.

One product label specifies: place 4 drops in a glass of water if used singly, or for a combination remedy use 2 drops of each. Sip occasionally throughout the day as required. Another commercially available product instructs users to take 2 drops or a full dropper under the tongue or in a beverage of choice and repeat as desired. Users may customize their own blend each day with up to 7 remedies.

One manufacturer states that their essence is made in a 1:240 "stock" strength. The finished product consists of grape alcohol (approximately 27% v/v) and flower extract of Mimulus.

In clinical trials involving teachers and children, dosing often mirrored traditional use, with remedies administered orally over several weeks. Most protocols suggest 2 to 4 times daily, adjusting based on need and practitioner advice.

Note: Dosing guidelines for Bach Flower Remedies are based more on traditional practice and practitioner experience than on rigorous scientific evidence.

Traditional Preparations (Ethnobotanical Record)

No standardized or measured dosages are recorded in the ethnobotanical literature for traditional Mimulus preparations. The Kawaiisu and others used decoctions of stems and leaves as a steam bath; the Shoshoni applied poultices of crushed leaves directly to wounds; and the Yavapai consumed a decoction as a tea. No quantitative dose data accompany these records.

Phytochemical Research (In Vitro)

In the antiparasitic in vitro study, all isolated compounds showed moderate antileishmanial activity against axenic Leishmania donovani amastigotes with IC₅₀ values ranging from 4.8 to 14.6 μg/mL. These values are derived from cell-culture assays and do not translate directly to human dosage recommendations.

---

7. Safety Considerations and Interactions

Safety Profile of Bach Flower Remedies (Including Mimulus Essence)

Most of the available evidence regarding the efficacy and safety of BFRs has a high risk of bias. Based on the reported adverse events in the six included trials, BFRs are probably safe. In total, only four adverse events were reported in subjects taking BFRs across those trials, suggesting a low acute adverse event burden at the dilutions used.

When taken by mouth, Bach flower remedies are possibly safe when used in moderation. Since most Bach flower remedies contain little or no active ingredient, these products are not expected to cause harm. But they are preserved in brandy and therefore contain alcohol.

Alcohol Content — Specific Interactions and Contraindications

The alcohol used as preservative in Bach flower essences is the primary documented safety concern. The remedies contain brandy, so a person taking disulfiram (Antabuse) for alcohol use disorder should avoid them. People who are pregnant or breastfeeding should also not use the remedies.

The Bach Centre in England recommends that persons taking disulfiram (Antabuse) as part of treatment for alcohol abuse should consult their physicians before using any of the Bach flower essences. Disulfiram works by changing the body's metabolism of alcohol in such a way that anyone taking the medication will experience nausea, dizziness, chest pains, and other unpleasant symptoms if they ingest even a small amount of alcohol. Although the amount of alcohol in four drops of Rescue Remedy is very small, it could conceivably trigger a reaction to disulfiram.

Stock solutions are preserved in alcohol, so those with sensitivities may wish to dilute further or allow the alcohol to evaporate before use.

Drug Interactions

Individuals should discuss any other medications they are taking with their healthcare provider, though no known drug interactions with Bach flower remedies exist beyond the disulfiram-alcohol interaction noted above.

Adverse Events

There are no documented cases of allergic reactions in the clinical literature, although as with any natural product, individual sensitivities cannot be entirely ruled out. No specific side effects have been reported in children or pregnant women, and the remedies have been used in pediatric and perinatal settings without adverse outcomes.

Safety of Leaves as Food

Mimulus guttatus is harvested from the wild for local use as a food and medicine, and no known hazards have been formally documented. The leaves have a long history of use as a food plant by multiple Native American cultures with no toxicity events recorded in the ethnobotanical literature.

Regulatory Status

Flower remedies are marketed as food supplements, avoiding legal efficacy requirements. In the United States, Bach flower essences are sold as dietary supplements and are not evaluated by the FDA for efficacy or safety. No WHO, EMA, ESCOP, or Commission E monograph exists specifically for Mimulus flower essence or plant extract. No official pharmacopeial monograph in the European Pharmacopoeia or USP covers Mimulus as a medicinal ingredient.

---

8. Summary of Evidence Strength

Across all areas of use associated with Mimulus, the current scientific evidence can be summarized as follows:

• Antiparasitic (anti-leishmanial / antitrypanosomal): Preliminary in vitro data only for isolated C-geranyl flavonoids from M. bigelovii. No animal studies or clinical trials exist. Evidence is at the earliest exploratory stage.
• Emotional wellbeing (Bach flower essence): Multiple systematic reviews of RCTs consistently find no statistically significant benefit beyond placebo. Evidence quality is low overall due to limited study numbers and methodological concerns, but the direction of findings does not support efficacy claims.
• Wound healing, analgesic, gastrointestinal uses: Traditional ethnobotanical use documented, no pharmacological or clinical studies conducted. Evidence is solely ethnobotanical and historical.
• Phytochemical characterization: Emerging and incomplete. The identification of phenylpropanoid glycosides in M. guttatus foliage and geranylated flavonoids in M. bigelovii is relatively recent (2011–2014) and provides a chemical foundation for future pharmacological investigation, but no clinical translation has occurred.

References

• Wikipedia: Mimulus
• Flora of North America: Mimulus
• Beardsley PM, Olmstead RG (2002). Redefining Phrymaceae: the placement of Mimulus, tribe Mimuleae, and Phryma. American Journal of Botany 89(7):1093–1102.
• Wikipedia: Erythranthe guttata (formerly Mimulus guttatus)
• Southwest Desert Flora: Mimulus guttatus, Seep Monkeyflower — Ethnobotanical uses
• Plants For A Future: Mimulus guttatus
• Useful Temperate Plants: Mimulus guttatus
• Keefover-Ring K et al. (2014). Phenylpropanoid glycosides of Mimulus guttatus (yellow monkeyflower). Phytochemistry Letters, 10, 132–139.
• Salem MM, Capers J, Rito S, Werbovetz KA (2011). Antiparasitic Activity of C-Geranyl Flavonoids from Mimulus bigelovii. Phytotherapy Research, 25(8):1246–1249. PubMed PMID: 21796699.
• Salem MM et al. (2011). Antiparasitic Activity of C‐Geranyl Flavonoids from Mimulus bigelovii. Phytotherapy Research. Wiley Online Library.
• Carotenoid composition of the flowers of Mimulus lewisii and related species. PubMed PMID: 25778629.
• Thaler K, Kaminski A, Chapman A, Langley T, Gartlehner G (2009). Bach Flower Remedies for psychological problems and pain: a systematic review. BMC Complementary and Alternative Medicine. PMC2695424.
• Ernst E (2010). Bach flower remedies: a systematic review of randomised clinical trials. Swiss Medical Weekly, 140:w13079.
• Database of Abstracts of Reviews of Effects (DARE): "Flower remedies": a systematic review of the clinical evidence. NCBI Bookshelf.
• Database of Abstracts of Reviews of Effects (DARE): Bach flower remedies: a systematic review of randomised clinical trials. NCBI Bookshelf.
• The Bach Centre: Mimulus — The Bach flower remedies guide.
• Medical News Today: Bach flower remedies — what they are, side effects, and more.
• Frontiers in Chemistry: Use of Natural Products in Leishmaniasis Chemotherapy — An Overview (2020).